Table 1 Characteristics of the 18 studies included in the systematic review and meta-analysis of peripheral artery disease among patients with DM in Sub-Saharan Africa
Study No | Author | Year | Country | Sub-Continent | Study design | Population | Prevalence | Sample Size | RR(%) |
|---|---|---|---|---|---|---|---|---|---|
1 | Akalu.Y et al. | 2020 | Ethiopia | East Africa | cross-sectional | T2DM | 30.7 | 280 | 100 |
2 | swali.A et al. | 2017 | Tanzania | East Africa | cross-sectional | T2DM | 30.7 | 367 | 100 |
3 | Osman.A et al. | 2023 | Sudan | East Africa | cross-sectional | T2DM | 22 | 100 | 100 |
4 | Agboghoroma et al. | 2020 | Nigeria | West Africa | cross-sectional | T2DM | 38.5 | 200 | 100 |
5 | Oyelade.B et al. | 2012 | Nigeria | West Africa | cross-sectional | DM | 52.5 | 219 | 100 |
6 | Okello. S et al. | 2014 | Uganda | East Africa | cross-sectional | DM | 43.64 | 229 | 100 |
7 | Immanuel.A et | 2016 | Ghana | West Africa | cross-sectional | T2DM | 35.5 | 200 | 100 |
8 | Yeboah.K et al. | 2016 | Ghana | West Africa | Case-control | DM | 26.7 | 815 | 100 |
9 | PD. Y et al. | 2018 | Nigeria | West Africa | cross-sectional | T2DM | 29 | 200 | 100 |
10 | Mwebaze. R et | 2014 | Uganda | East Africa | cross-sectional | DM | 39 | 146 | 100 |
11 | ACA.C et al. | 2019 | Nigeria | West Africa | cross-sectional | T2DM | 31.1 | 405 | 100 |
12 | Weledji.E et al. | 2018 | Cameroon | Central Africa | cross-sectional | DM | 18 | 214 | 100 |
13 | Ogbera. A et al. | 2015 | Nigeria | West Africa | cross-sectional | DM | 40 | 225 | 100 |
14 | Mahamet.A et al. | 2024 | Chad | Central Africa | cross-sectional | DM | 21.2 | 782 | 100 |
15 | Abbas.Z et al. | 2020 | Tanzania | East Africa | cross-sectional | DM | 28 | 5,687 | 100 |
16 | Anumah. F et al. | 2023 | Nigeria | West Africa | cross-sectional | DM | 34.3 | 1,040 | 100 |
17 | Codjo.H et al. | 2016 | Benin | West Africa | cross-sectional | DM | 41.9 | 401 | 100 |
18 | Umuerri. EM et al. | 2013 | Nigeria | West Africa | cross-sectional | T2DM | 35.6 | 388 | 100 |